Two novel mutations in the MPZ gene coding region in Charcot-Marie-Tooth type 1 patients of Turkish origin: S54P, [I30del; GVYI29ins]

1999 ◽  
Vol 14 (5) ◽  
pp. 449-449 ◽  
Author(s):  
Nisrine Bissar-Tadmouri ◽  
Yesim Gulsen-Parman ◽  
Philippe Latour ◽  
Feza Deymeer ◽  
Piraye Serdaroglu ◽  
...  
1999 ◽  
Vol 13 (4) ◽  
pp. 339-339 ◽  
Author(s):  
Charalampos Karadimas ◽  
Marios Panas ◽  
Penelope Chronopoulou ◽  
Dimitrios Avramopoulos ◽  
Demetrios Vassilopoulos

1994 ◽  
Vol 34 (3) ◽  
pp. 135-139 ◽  
Author(s):  
G.L. Mancardi ◽  
A. Uccelli ◽  
E. Bellone ◽  
A. Sghirlanzoni ◽  
P. Mandich ◽  
...  

2003 ◽  
Vol 48 (10) ◽  
pp. 545-549 ◽  
Author(s):  
Ming-Tzen Liu ◽  
Jih-Shyun Su ◽  
Chun-Yu Huang ◽  
Shih-Feng Tsai

2000 ◽  
Vol 21 (2) ◽  
pp. 109-112 ◽  
Author(s):  
G. Di Iorio ◽  
V. Cappa ◽  
A. Ciccodicola ◽  
S. Sampaolo ◽  
A. Ammendola ◽  
...  

2009 ◽  
Vol 19 (7) ◽  
pp. 476-480 ◽  
Author(s):  
Isabella Moroni ◽  
Michela Morbin ◽  
Micaela Milani ◽  
Claudia Ciano ◽  
Marianna Bugiani ◽  
...  

2009 ◽  
Vol 56 (4) ◽  
Author(s):  
Izabela Moszyńska ◽  
Dagmara Kabzińska ◽  
Elena Sinkiewicz-Darol ◽  
Andrzej Kochański

Hereditary neuropathy with liability to pressure palsies (HNPP) is manifested by a spectrum of phenotypes, from the classical HNPP course associated with intermittent nerve palsies to a neuropathy resembling Charcot-Marie-Tooth type 1 (CMT1) disease. The majority of HNPP cases are associated with submicroscopical deletions in the 17p11.2-p12 region containing the PMP22 gene, while PMP22 point mutations are rare, representing about 15% of HNPP cases. In this study, we present a patient manifesting with atypical HNPP phenotype associated with a new Thr99fsX110 mutation in the PMP22 gene. We conclude that all patients who fulfill the electrophysiological criteria of HNPP, even if they lack the typical HNPP phenotype, should be tested for point mutations in the PMP22 gene.


Sign in / Sign up

Export Citation Format

Share Document